Logo image of TPGY

TPG Pace Beneficial Finance Corp (TPGY) Stock Fundamental Analysis

NYSE:TPGY - New York Stock Exchange, Inc. - KYG8990D1253 - Common Stock - Currency: USD

10.04  +0.01 (+0.1%)

After market: 10.04 0 (0%)

Fundamental Rating

2

Overall TPGY gets a fundamental rating of 2 out of 10. We evaluated TPGY against 0 industry peers in the Unkown industry. The financial health of TPGY is average, but there are quite some concerns on its profitability. TPGY has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

TPGY had positive earnings in the past year.
TPGY Yearly Net Income VS EBIT VS OCF VS FCFTPGY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 0 200M -200M

1.2 Ratios

Industry RankSector Rank
ROA 23.9%
ROE 25.13%
ROIC 1.45%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TPGY Yearly ROA, ROE, ROICTPGY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 0 -1K -2K -3K -4K

1.3 Margins

TPGY does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TPGY Yearly Profit, Operating, Gross MarginsTPGY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021

More info and screens

4

2. Health

2.1 Basic Checks

TPGY has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for TPGY is higher compared to a year ago.
TPGY Yearly Shares OutstandingTPGY Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 10M 20M 30M 40M
TPGY Yearly Total Debt VS Total AssetsTPGY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 100M 200M 300M

2.2 Solvency

An Altman-Z score of 15.16 indicates that TPGY is not in any danger for bankruptcy at the moment.
There is no outstanding debt for TPGY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 15.16
ROIC/WACCN/A
WACCN/A
TPGY Yearly LT Debt VS Equity VS FCFTPGY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 100M 200M 300M

2.3 Liquidity

TPGY has a Current Ratio of 0.86. This is a bad value and indicates that TPGY is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.86 indicates that TPGY may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.86
TPGY Yearly Current Assets VS Current LiabilitesTPGY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 100M 200M 300M

More info and screens

1

3. Growth

3.1 Past

TPGY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 186.55%, which is quite impressive.
EPS 1Y (TTM)186.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-96.94%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y31.94%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year87.85%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TPGY Yearly Revenue VS EstimatesTPGY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 50M 100M 150M 200M 250M
TPGY Yearly EPS VS EstimatesTPGY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 -0.2 -0.4 -0.6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 5.18, which indicates a rather cheap valuation of TPGY.
When comparing the Price/Earnings ratio of TPGY to the average of the S&P500 Index (28.79), we can say TPGY is valued rather cheaply.
TPGY is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 5.18
Fwd PE N/A
TPGY Price Earnings VS Forward Price EarningsTPGY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TPGY Per share dataTPGY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.16
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TPGY!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TPG Pace Beneficial Finance Corp

NYSE:TPGY (10/7/2022, 8:17:17 PM)

After market: 10.04 0 (0%)

10.04

+0.01 (+0.1%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-10 2022-08-10
Earnings (Next)11-07 2022-11-07
Inst Owners0%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap439.25M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.18
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.3
P/tB N/A
EV/EBITDA N/A
EPS(TTM)1.94
EY19.32%
EPS(NY)-0.5
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS7.72
TBVpSN/A
PEG (NY)0.16
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 23.9%
ROE 25.13%
ROCE N/A
ROIC 1.45%
ROICexc N/A
ROICexgc 1.45%
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.86
Quick Ratio 0.86
Altman-Z 15.16
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)186.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-96.94%
EPS Next Y31.94%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year87.85%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A